Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Registration
    • Conference Registration
    • Exhibitor Registration
    • Hotel Reservations
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • App View

Development of Avicequinone Analogs to Treat Androgenic Alopecia

Undergraduate #5
Discipline: Biological Sciences
Subcategory: Biochemistry (not Cell and Molecular Biology and Genetics)

Dirk Glen Jr. - Howard University
Co-Author(s): How Tug and Woraanong Prugsakij, Chulalongkorn University, Bangkok, Thailand



Androgenic Alopecia is the genetic predisposed unnatural hair loss in humans and affects up to 60 to 70 % of the population worldwide. This condition is more prevalent in Men, affecting up to 50% by age 50 and up to 70% in later life. In this experiment we were attempting to identify the level of activity of Avicequinone Analogs to treat Androgenic Alopecia through the inhibitory mechanism of 5α-reductase. From the research we have gathered so far, we have high hopes for the inhibitory capabilities of WNK-6, a compound we synthesized. The research design tested the inhibitory effects of our experimental compounds against controls such as Dutasteride and testosterone in TLC gels. Dutasteride was used as a positive control, as it inhibits the production of DHT at a 1 to 1 ratio. The results from the TLC gel were inconclusive because of the lack of testosterone in our experimental compounds column. The inconclusiveness of this experiment points to error that could have been made during the RT-PCR phase of the experiment, whether it was improper annealing of the RNA, or error in synthesis of the cDNA. Further research will aim to eliminate error in data collection that could have led to inconclusive results. Also, fine-tuning a more effective method in the phases of testing could also lead to more conclusive results.

Funder Acknowledgement(s): This material is based upon work supported by the National Science Foundation under Grant No. HRD-1238466. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.

Faculty Advisor: Tiffany Lathan,

ERN Conference

Celebrating 10 years of ERN!

What’s New

  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • #ShutDownSTEM
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

Navigation

  • About the ERN Conference
  • Partners/Supporters
  • Abstracts
  • Travel Awards
  • Conference Registration
  • Exhibitor Registration
  • Hotel Reservations

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2021 American Association for the Advancement of Science